IFM Investors Pty Ltd Sells 861 Shares of Revvity, Inc. (NYSE:RVTY)

IFM Investors Pty Ltd cut its stake in shares of Revvity, Inc. (NYSE:RVTY) by 3.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,984 shares of the company’s stock after selling 861 shares during the quarter. IFM Investors Pty Ltd’s holdings in Revvity were worth $2,623,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of RVTY. Sumitomo Mitsui Trust Holdings Inc. boosted its position in Revvity by 3.3% during the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 317,292 shares of the company’s stock valued at $33,316,000 after buying an additional 10,198 shares during the period. Oak Thistle LLC bought a new position in shares of Revvity during the first quarter valued at about $607,000. Artemis Investment Management LLP boosted its holdings in shares of Revvity by 80.5% during the first quarter. Artemis Investment Management LLP now owns 88,718 shares of the company’s stock worth $9,311,000 after purchasing an additional 39,573 shares during the period. RDA Financial Network bought a new stake in shares of Revvity in the first quarter worth about $322,000. Finally, Gulf International Bank UK Ltd increased its holdings in Revvity by 3.8% during the 1st quarter. Gulf International Bank UK Ltd now owns 10,795 shares of the company’s stock valued at $1,133,000 after purchasing an additional 400 shares during the period. 86.65% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on RVTY. Stifel Nicolaus raised their target price on shares of Revvity from $95.00 to $110.00 and gave the stock a “hold” rating in a research report on Friday, February 2nd. KeyCorp raised their price target on Revvity from $110.00 to $126.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. UBS Group downgraded shares of Revvity from a “buy” rating to a “neutral” rating and increased their price objective for the company from $105.00 to $125.00 in a research report on Tuesday, January 16th. Evercore ISI upgraded shares of Revvity from an “in-line” rating to an “outperform” rating and upped their target price for the stock from $88.00 to $125.00 in a research note on Thursday, January 4th. Finally, Raymond James boosted their target price on Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Revvity currently has a consensus rating of “Moderate Buy” and an average price target of $118.91.

Revvity Stock Performance

Shares of Revvity stock traded down $0.58 on Friday, hitting $101.51. 827,386 shares of the company’s stock were exchanged, compared to its average volume of 939,494. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.77 and a current ratio of 2.07. The stock has a market capitalization of $12.54 billion, a PE ratio of 18.46, a PEG ratio of 2.66 and a beta of 1.09. Revvity, Inc. has a 1 year low of $79.50 and a 1 year high of $132.54. The company has a 50-day simple moving average of $104.66 and a 200-day simple moving average of $101.46.

Revvity (NYSE:RVTY) last released its earnings results on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.10. Revvity had a return on equity of 7.41% and a net margin of 25.20%. The company had revenue of $695.90 million for the quarter. As a group, equities analysts anticipate that Revvity, Inc. will post 4.65 EPS for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, July 19th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. Revvity’s dividend payout ratio (DPR) is presently 5.09%.

Insider Buying and Selling

In other news, insider Prahlad R. Singh sold 21,217 shares of the firm’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the sale, the insider now directly owns 92,801 shares in the company, valued at approximately $9,677,288.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.60% of the stock is currently owned by insiders.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.